首页> Anti-cancer agents in medicinal chemistry> ESM-1: A Novel Tumor Biomaker and its Research Advances.

ESM-1: A Novel Tumor Biomaker and its Research Advances.

导出 LinkOut

翻译打印收藏纠错

第一作者： Chen,Li

第一单位： Qinghai University Graduate School, Xining, China.

作者： Chen,Li ^[1] ; Hui,Geng ^[2] ; Linhua,Ji ^[2] ; Xiaojing,Ma ^[2] ; Qichao,Yin ^[2] ; Hua,Xiong ^[2]

作者单位： Qinghai University Graduate School, Xining, China. ^[1] Department of Haematology, The Affiliated Hospital of Qinghai University, Xining, China. ^[2]

关键词 Endocan HGF/SF HIF VEGF mechanism tumor.

医学主题词动物(Animals);细胞增殖(Cell Proliferation);人类(Humans);肿瘤蛋白质类(Neoplasm Proteins);肿瘤(Neoplasms);蛋白聚糖类(Proteoglycans)

DOI 10.2174/1871520619666190705151542

PMID 31284875

发布时间 2020-08-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Anti-cancer agents in medicinal chemistry

2019年19卷14期

1687-1694页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览9

点击下载本期目录封面

Anti-cancer agents in medicinal chemistry

2019年19卷14期

1687-1694页

检索历史清除

ESM-1: A Novel Tumor Biomaker and its Research Advances.

Anti-cancer agents in medicinal chemistry

相似文献

同项目论文

Anti-cancer agents in medicinal chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

ESM-1: A Novel Tumor Biomaker and its Research Advances.

Anti-cancer agents in medicinal chemistry

相似文献

同项目论文

Anti-cancer agents in medicinal chemistry

相关期刊

检索历史清除